NCT02550847
Unknown
Not Applicable
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
ConditionsPancreatic Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreatic Cancer
- Sponsor
- National Taiwan University Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- The tumor recurrence rate after operation at 6 months
- Last Updated
- 10 years ago
Overview
Brief Summary
The aim of this study was to evaluate MR/PET with both functional and molecular imaging on the prediction of prognosis in patients with suspected pancreatic cancer.
Detailed Description
The results of MR/PET will be compared prospectively to dedicated MDCT or MR imaging, pathologic results, and clinical outcomes to assess the value of MR/PET in pancreatic cancers.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed as pancreatic cancer
- •Between 20\~90 years old
- •Normal renal function
- •Measurable tumor size (\>1cm)
Exclusion Criteria
- •Contraindication for MRI exam
- •Claustrophobia
- •Renal insufficiency
- •Other malignancy
- •Pregnancy and lactating women
Outcomes
Primary Outcomes
The tumor recurrence rate after operation at 6 months
Time Frame: 6 months
Secondary Outcomes
- The overall survival after operation at 6 months(6 months)
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedCervical Undifferentiated CarcinomaRecurrent Cervical CarcinomaStage IB2 Cervical CancerStage II Cervical CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage IIIA Cervical CancerStage IIIB Cervical CancerStage IVA Cervical CancerNCT01992861University of Washington51
Completed
Not Applicable
PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast CancerBreast CancerNCT01190566Seoul National University Hospital57
Unknown
Not Applicable
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular CarcinomaHepatocellular CarcinomaNCT02550613National Taiwan University Hospital100
Not yet recruiting
Phase 2
PET/MRI in Rectal CancerRectal CancerNCT06057831AHS Cancer Control Alberta40
Completed
Not Applicable
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility StudyIBDNCT02364973Turku University Hospital20